Gene · 10507
Papers1,823
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,823
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Plexins: Navigating through the neural regulation and brain pathology. | Neurosci Biobehav Rev | 2025 | 39756719 | PubTator, text mining | PubMed |
| B-type Plexins Regulate Mitosis via RanGTPase. | Mol Cancer Res | 2025 | 39136653 | PubTator, text mining | PubMed |
| Screening for Biomarkers Related to Pigmentation and Formation in Vitiligo. | Comb Chem High Throughput Screen | 2025 | 38231049 | PubTator, text mining | PubMed |
| Integrins and NAFLD-associated liver diseases: clinical associations, pathophysiological mechanisms and pharmacological implications. | Acta Biochim Biophys Sin (Shanghai) | 2024 | 40384047 | PubTator, text mining | PubMed |
| The Role of Immune Semaphorins in Sepsis-A Prospective Cohort Study. | Microorganisms | 2024 | 39770766 | PubTator, text mining | PubMed |
| Carcinoma-Astrocyte Gap Junction Interruption by a Dual-Targeted Biomimetic Liposomal System to Attenuate Chemoresistance and Treat Brain Metastasis. | ACS Nano | 2024 | 39626120 | PubTator, text mining | PubMed |
| Participation of Semaphorin Family and Plexins in the Clinical Course of Patients with Inflammatory Bowel Disease. | Int J Mol Sci | 2024 | 39596507 | PubTator, text mining | PubMed |
| PLXNB1/SEMA4D signals mediate interactions between malignant epithelial and immune cells to promote colorectal cancer liver metastasis. | J Cell Mol Med | 2024 | 39443302 | PubTator, text mining | PubMed |
| Cancer immunotherapy by γδ T cells. | Science | 2024 | 39361750 | PubTator, text mining | PubMed |
| Survival benefit of sequential curative treatment for TACE suitable BCLC stage B HCC patients. | Sci Rep | 2024 | 39343774 | PubTator, text mining | PubMed |
| Sema4D deficiency enhances glucose tolerance through GLUT2 retention in hepatocytes. | J Transl Med | 2024 | 39334386 | PubTator, text mining | PubMed |
| Associations of SEMA7A, SEMA4D, ADAMTS10, and ADAM8 with KRAS, NRAS, BRAF, PIK3CA, and AKT Gene Mutations, Microsatellite Instability Status, and Cytokine Expression in Colorectal Cancer Tissue. | Curr Issues Mol Biol | 2024 | 39329961 | PubTator, text mining | PubMed |
| Comparison of Class II Bulk-Fill, Self-Adhesive Composites, Alkasite, and High-Viscosity Glass Ionomer Restorations in Terms of Marginal and Internal Adaptation. | Materials (Basel) | 2024 | 39274764 | PubTator, text mining | PubMed |
| Altered memory CCR6+ Th17-polarised T-cell function and biology in people with HIV under successful antiretroviral therapy and HIV elite controllers. | EBioMedicine | 2024 | 39178742 | PubTator, text mining | PubMed |
Phase I studies of davoceticept (ALPN-202), a PD-L1-dependent CD28 co-stimulator and dual PD-L1/CTLA-4 inhibitor, as monotherapy and in combination with pembrolizumab in advanced solid tumors (NEON-1 and NEON-2). | J Immunother Cancer | 2024 | 39097413 | PubTator, text mining | PubMed |
| A genome-wide association meta-analysis of all-cause and vascular dementia. | Alzheimers Dement | 2024 | 39046104 | PubTator, text mining | PubMed |
| Early rhombic lip Protogenin+ve stem cells in a human-specific neurovascular niche initiate and maintain group 3 medulloblastoma. | Cell | 2024 | 38971152 | PubTator, text mining | PubMed |
| Sema4D Knockout Attenuates Choroidal Neovascularization by Inhibiting M2 Macrophage Polarization Via Regulation of the RhoA/ROCK Pathway. | Invest Ophthalmol Vis Sci | 2024 | 38913005 | PubTator, text mining | PubMed |
| Histological pattern of tumor inflammation and stromal density correlate with patient demographics and immuno-oncologic transcriptional profile in oral squamous cell carcinoma. | Front Oral Health | 2024 | 38903181 | PubTator, text mining | PubMed |
| Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma. | J Clin Oncol | 2024 | 38879802 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10507/papers?page=5